Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,293
Closed -$298K 540
2022
Q2
$298K Buy
4,293
+3,264
+317% +$242K 0.12% 258
2022
Q1
$79K Sell
1,029
-774
-43% -$55.7K 0.03% 451
2021
Q4
$138K Sell
1,803
-1,317
-42% -$96.8K 0.06% 393
2021
Q3
$230K Sell
3,120
-5,810
-65% -$436K 0.09% 316
2021
Q2
$596K Buy
8,930
+6,657
+293% +$445K 0.22% 160
2021
Q1
$169K Sell
2,273
-330
-13% -$25.1K 0.07% 329
2020
Q4
$190K Buy
+2,603
New +$184K 0.07% 263

Other funds holding HOLX

Alpha Paradigm Partners's HOLX Position: Q3 2022 in Review

Alpha Paradigm Partners sold out of Hologic (HOLX) in Q3 2022, closing a stake of 4,293 shares — an estimated $298K sold.

Alpha Paradigm Partners first reported a position in HOLX in Q4 2020 and held it in 7 quarters. The position peaked at $596K in Q2 2021. 653 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

  • Alpha Paradigm Partners reported no remaining Hologic position as of Q3 2022 after selling out during the quarter.
  • Alpha Paradigm Partners sold 4,293 Hologic shares in Q3 2022, an estimated $298K.
  • Alpha Paradigm Partners first reported a position in Hologic in Q4 2020 and held it in 7 quarters.
  • Alpha Paradigm Partners's Hologic position peaked at $596K in Q2 2021.
  • 653 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Alpha Paradigm Partners's 13F filing for Q3 2022, filed 15 Nov 2022.